Seboreisk dermatitt
Sist oppdatert: Sist revidert:
Sist revidert av:Terje JohannessenDefinisjon:
Kronisk, skjellende eksem med ukjent årsak. Soppen Malassezia er sannsynligvis en nødvendig faktor. Stress og søvnmangel kan forverre. Immunsuppresjon disponerer
Forekomst:
Hyppigst hos spedbarn, hos voksne i 3. og 4. dekade og hos eldre
Symptomer:
Varierer fra vanlig flass til hissigere inflammasjon og skjellende eksemforandringer
Funn:
Forandringene ses hyppigst i hodebunn, øyebryn og perinasalt, øvre deler av trunkus, armhuler og lyske
Diagnostikk:
Ingen diagnostiske prøver, kun aktuelt ved usikker diagnose (f.eks. hudbiopsi)
Behandling:
Viktigste er lokalbehandling med azolderivater. Behandlingen er ikke helbredende
- Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician 2015 Feb 1;91(3):185-190.
- Sasseville D. Seborrheic dermatitis in adolescents and adults. UpToDate, last updated Mar 26, 2020. www.uptodate.com
- Gupta AK, Madzia SE, Batra R. Etiology and management of seborrheic dermatitis. Dermatology 2004; 208: 89-93. PubMed
- Foley P, Zuo Y, Plunkett A, Merlin K, Marks R. The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap). Arch Dermatol 2003; 139: 318-22. PubMed
- Mastrolonardo M, Diaferio A, Vendemiale G, Lopalco P. Seborrhoeic dermatitis in the elderly: inferences on the possible role of disability and loss of self-sufficiency. Acta Derm Venereol 2004; 84: 285-7. PubMed
- Mastrolonardo M, Diaferio A, Logroscino G. Seborrheic dermatitis, increased sebum excretion, and Parkinson's disease: a survey of (im)possible links. Med Hypotheses 2003; 60: 907-11. PubMed
- Piérard GE. Seborrheic dermatitis today, gone tomorrow? The link between the biocene and treatment. Dermatology 2003; 206:187-8. PubMed
- Schwartz RA. Superficial fungal infections. Lancet 2004; 364: 1173-82. PubMed
- Handler MZ. Seborrheic dermatitis. Medscape, last updated Aug 13, 2019. emedicine.medscape.com
- Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25(1):106–141.
- Viodé C, Lejeune O, Turlier V, et al. Cathepsin S, a new pruritus biomarker in clinical dandruff/seborrhoeic dermatitis evaluation. Exp Dermatol. 2014;23(4):274–275.
- Schwartz JR, Messenger AG, Tosti A, et al. A comprehensive pathophysiology of dandruff and seborrheic dermatitis - towards a more precise definition of scalp health. Acta Derm Venereol. 2013;93(2):131–137.
- Janniger CK, Schwartz RA. Seborrhoeic dermatitis. BMJ Best Practice, last updated Feb 13, 2017. bestpractice.bmj.com
- Statens legemiddelverk. Terapianbefaling: Behandling av dermatomykoser. Nytt om legemidler 2005; 28 (2): 28-33.
- Kastarinen H, Oksanen T, Okokon EO, et al. Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp. Cochrane Database Syst Rev. 2014; 5: CD009446. PMID: 24838779 PubMed
- Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN. Topical antifungals for seborrhoeic dermatitis. Cochrane Database of Systematic Reviews 2015, Issue 5. Art. No.: CD008138. DOI: 10.1002/14651858.CD008138.pub3. DOI
- Squire RA, Goode K. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis. J Dermatolog Treat 2002; 13: 51-60. PubMed
- Chosidow O, Maurette C, Dupuy P. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. Dermatology 2003; 206: 233-40. PubMed
- Milani M, Antonio Di Molfetta S, Gramazio R, Fiorella C, Frisario C, Fuzio E, et al. Efficacy of betamethasone valerate 0.1% thermophobic foam in seborrhoeic dermatitis of the scalp: an open-label, multicentre, prospective trial on 180 patients. Curr Med Res Opin 2003; 19: 342-5. PubMed
- Reichrath J. Antimycotics: why are they effective in the treatment of seborrheic dermatitis? Dermatology 2004; 208: 174-5. PubMed
- Schwartz JR, Rocchetta H, Asawanonda P, Luo F, Thomas JH. Does tachyphylaxis occur in long-term management of scalp seborrheic dermatitis with pyrithione zinc-based treatments? Int J Dermatol. 2009;48(1):79–85.
- Cook BA, Warshaw EM. Role of topical calcineurin inhibitors in the treatment of seborrheic dermatitis: a review of pathophysiology, safety, and efficacy. Am J Clin Dermatol. 2009. 10(2):103-18.
- Ang-Tiu CU, Meghrajani CF, Maano CC. Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol. 2012;5(1):91–97.
- Ooi ET, Tidman MJ. Improving the management of seborrhoeic dermatitis. Practitioner. 2014;258(1768):23–26.
- Terje Johannessen, professor i allmennmedisin, Trondheim
Tidligere fagmedarbeidere
- Kurt Østhuus Krogh, spesialist i barnesykdommer, Redaksjonsmedarbeider NHI/ overlege Barne- og ungdomsklinikken, St. Olavs Hospital
- Sylvi Torvund, spesialist i allmennmedisin, Nidarvold legesenter, Trondheim
- Morten Dalaker, avtalespesialist i hudsykdommer, Trondheim Hudlegesenter, Carl Johans gt 3, 7010 Trondheim